Siliq: The Lowest Priced Psoriasis Treatment at $3,500 per month

Ahead of an expected U.S. launch in the second half of 2017, Canadian drugmaker Valeant Pharmaceuticals International Inc. said it had priced its recently approved plaque psoriasis treatment (Siliq) at $3,500 per month; it will be the lowest priced injectable biologic psoriasis treatment currently on the market. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply